Nov. 20, 2024 — Researchers shrink gastrointestinal tumors in mice using a yeast probiotic to deliver immunotherapy to the gut, offering a potentially novel strategy to target hard-to-reach gut ...

A 17-year-old white male with a 9-year history of ileocolonic Crohn's disease developed a skin rash while receiving infliximab, a chimeric IgG1κ monoclonal antibody against tumor necrosis factor ...

Nov. 12, 2024 — Glioblastoma is the most common kind of malignant brain tumor in adults. So far, no treatment has been able to make this aggressive tumor permanently disappear. The tumor cells ...

It's a core function, but little studied in the setting of cancer immunology, ... The spread of tumor from the primary cancer site to distant organs, called metastasis, has puzzled scientists for ...

More than 66,000 Americans will be diagnosed with pancreatic cancer this year. Learn more about the disease and how PanCAN can help.

Colon cancer usually doesn’t cause symptoms in the early stages. As the disease progresses, you may experience abdominal pain, rectal bleeding, and changes in the size and shape of your stool.

All the things! Your schedule may be full to the brim during Virgo's last quarter moon. Getting your strategy together? You’ll need to be organized to make a sizable dent. Let go of unattainable ...

Tumour heterogeneity describes differences between tumours of the same type in different patients, and between cancer cells within a tumour. Both can lead to different responses to therapy.

Most of the time the diagnostic blockade and the RFA are carried out on separate occasions; however, in cancer patients the practioner may opt to do both of them at the same time. Radiofrequency ...

Ahead of print articles are peer reviewed, accepted articles to be published in this publication. When the final article is assigned to volumes/issues of the publication, the ahead of print article ...